Glyceryl trinitrate spray in the management of painful diabetic neuropathy: A randomized double blind placebo controlled cross-over study

Diabetes Research and Clinical Practice

Volumn 77, Issue 2, 2007, Pages 161-167

  Agrawal, R P ^a   Choudhary, Ramdev ^a   Sharma, Poornima ^a   Sharma, Srikant ^a   Beniwal, R ^a   Kaswan, K ^a   Kochar, D K ^a  

^a S P MEDICAL COLLEGE   (India)

Author keywords

Diabetic neuropathy; Glyceryl trinitrate spray

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; BACLOFEN; CAPSAICIN DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DULOXETINE; GABAPENTIN; GAMMA LINOLENIC ACID; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; HEMOGLOBIN A1C; INSULIN; LIDOCAINE; MEXILETINE; NARCOTIC ANALGESIC AGENT; NERVE GROWTH FACTOR; NUCLEOSIDE; OPIATE; OXYCODONE; PLACEBO; PREGABALIN; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ABSENCE OF SIDE EFFECTS; AEROSOL; ANALGESIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME ACTIVATION; FAINTNESS; HEADACHE; HEART PALPITATION; HUMAN; NAUSEA; NEUROPATHIC PAIN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SOMNOLENCE; UNSPECIFIED SIDE EFFECT; VASODILATATION; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MIDDLE AGED; NITROGLYCERIN; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 34247615434     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.12.003     Document Type: Review

References (33)

1. Hoke A., and Feasby T. Disorders of the peripheral nervous system. In: Homes H. (Ed). Kelley's Textbook of Internal Medicine (2000), Lippincolt Williams and Wilkins, Philadelphia 2980-2981
2. Argoff C.E., Backonja M.-M., Belgrade M.J., Bennett G.J., Clark M.R., Cole B.E., et al. Consensus guidelines: treatment planning and options. Mayo Clin. Proc. 81 4 Suppl. (2006) 512-525
3. Sasaki T., Yasuda H., Maeda K., and Kikkwa R. Hyperlagesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreprot 9 (1998) 243-247
4. Rodella L., Rezzani R., Corsetti G., and Bianchi R. Nitric oxide involvement in the trigeminal hyperalgesia in diabetic rats. Brain Res. 865 (2000) 112-115
5. Pitei D.L., Watkins P.J., and Edmonds M.E. Nitric oxide is reduced in NIDDM patients with peripheral sensory neuropathy. Diabetic Med. 14 (1997) 284-290
6. Molina C., Anderson J.W., Rapaport R.M., Waldman S.A., and Murad F. Effects of in vivo nitroglycerin therapy on endothelium-dependent and independent relaxation and cyclic GMP accumulation in rat arota. J. Cardiovasc. Pharmacol. 10 (1987) 371-378
7. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78 (1986) 1-5
8. Kevin C.J., Baker N.R., and Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray. Diabetes Care 25 (2002) 1699-1703
9. Max M.B., Culname M., Schafer S.C., et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37 (1987) 589
10. D.J. Goldstein, Y. Lv, M.J. Dekte, T.C. Lee, S. Iyengar, Duloxetine vs. placebo in patients with painful diabetic neuropathy pain 116 (2005) 109-118.
11. Smith T.R. Duloxetine in diabetic neuropathy. Expert Opin. Pharmacother. 7 2 (2006) 215-223
12. Rowbotham M.C., Goli V., Kunz N.R., and Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 110 3 (2004) 697-706
13. Gilron I., and Flatters S.J. Gabapentin and pregabalin for the treatment of neuropathic pain: a review of laboratory and clinical evidence. Pain Res. Manag. 11 Suppl (2006) 16A-29A
14. Lyrica study group, Pregabalin for peripheral neuropathic pain: results of a multicenter, non-comparative, open-label study in indian patients, Int. J. Clin. Pract. 60(9) (2006) 1060-1067.
15. Backonja M., Beydown A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetic mellitus. JAMM 280 (1998) 1831-1836
16. Kochar D.K., Jain N., Agrawal R.P., Srivastava T., Agrawal P., and Gupta S. Sodium valproate in the management of painful neuropathy in type-2 diabetes-a randomized placebo controlled study. Acta Neurol. Scand. 106 (2002) 248-252
17. Kochar D.K., Rawat N., Agrawal R.P., Vyas A., Beniwal R., Kochar S.K., et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. Q. J. Med. 97 (2004) 33-38
18. Rull J.A., Quiberera R., Gonzalez Millan H., et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia 5 (1969) 215
19. Willon T.D. Tegretol in the treatment of diabetic neuropathy. S. Afr. Med. J. 48 (1974) 869
20. Chakarbarti A.K., and Samantary S.K. Diabetic peripheral neuropathy. Nerve conduction studies before, during and after carbamazepine therapy. Austr. N.Z. Med. 6 (1976) 565
21. Capsaicin Study Group. Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 15 (1992) 159
22. Boulton A.J.M., Levin S., and Comstock J. A multicentre trial of the aldose reductase inhibitor tolerastat in patients symptomatic neuropathy. Diabetologia 33 (1990) 431
23. Crepaldi G., Fedele D., Tiengo A., et al. Ganglioside treatment in diabetic peripheral neuropathy: a multicenter trial. Acta Diabetol. Lat. 10 (1983) 265
24. Dejgard A., Peterson P., and Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1 (1988) 9
25. Dyck P.J. Nerve growth factor and diabetic neuropathy. Lancet 348 (1996) 1044-1045
26. Viola V., Newnham H.H., and Simpson R.W. Treatment of intractable painful diabetic neuropathy with intravenous lignocaine. Diabetes Compl. 20 1 (2006) 34-39
27. Watson C.P., Moulin D., Watt-Watson J., et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 105 (2003) 71-78
28. Harati Y., Gooch, Swenson M., et al. Maintenance of the long term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J. Diabetes Compl. 14 (2000) 65-70
29. Tandan R., Lewis G.A., and Krusinski P.B. Topical capsaicin in painful diabetic neuropathy. Diabetes Care 15 (1992) 8
30. Barbano R.L., Herrmann D.N., Hart-Gouleav S., et al. Effectiveness, tolerability and impact on quality of life of the 5% lidocaine patch in diabetic neuropathy. Arch. Neurol. 61 (2004) 914-918
31. Cohen K.L., and Harris S. Efficacy and safety of non-steroidal anti-inflammatory drugs in the therapy of diabetic neuropathy. Arch. Intern. Med. 147 (1987) 1442-1444
32. Melzack R., and Wall P.D. Pain mechanisms a new theory. Science 150 (1965) 971-979
33. Archer A.G., Watkins P.J., Thomas P.K., Sharma A.K., and Payan J. Natural history of acute painful neuropathy in diabetes mellitus. J. Neurol. Neurosurg. Psych. 46 (1983) 491-499